| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.35 | 6e-07 |